Please Note: Blog posts are not selected, edited or screened by Seeking Alpha editors.

Aerocrine AB Treating Inflammatory Airway Diseases

Aerocrine AB is a Sweden-based medical technology company focused on improving the treatment and care of patients with inflammatory airway diseases, such as asthma. It develops various devices and clinical applications for the monitoring of inflammation through the measurement of gaseous markers, comprising exhaled nitric oxide (NO). The Company's product portfolio includes NIOX MINO, a hand-held device for measuring airway inflammation, and NIOX Flex, which is offered primarily to the research market. As of December 31, 2010, the Company operated through four wholly owned subsidiaries: Aerocrine Inc. in the United States, Aerocrine AG in Germany, Aerocrine Ltd in the United Kingdom and Aerocrine ESOP AB in Sweden.